Skip to Content

L 12 (Letrozole 2.5 mg)

Pill with imprint L 12 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Lannett Company, Inc..

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L 12

Letrozole

Imprint:
L 12
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Lannett Company, Inc.
National Drug Code (NDC):
00527-1712

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide